The descriptions of Enterobacter taylorae and Enterobacter cancerogenus show differences in key reactions (ornithine decarboxylase and D-sorbitol fermentation) that have not received attention and are inconsistent with the synonymy proposed by Grimont and Ageron (P. A. D, Grimont and E. Ageron, Res. Microbiol. 140459-465, 1989). A reassessment of the biochemical properties confirms that they are synonymous. We believe that the priority of E. cancerogenus should be maintained in diagnostic and clinical microbiology even if the epithet could be misunderstood in a clinical setting.
The descriptions of Enterobacter taylorae and Enterobacter cancerogenus show differences in key reactions (ornithine decarboxylase and D-sorbitol fermentation) that have not received attention and are inconsistent with the synonymy proposed by Grimont (1) . Although a positive reaction for omithine (and arginine) decarboxylase was mentioned among the arguments for reassessing the relationship of E. cancerogena to the genus Enterobacter, a negative ornithine decarboxylase reaction was listed in the description of the species based on three strains, including NCPPB 2176. Moreover, acid from D-sorbitol was given as positive within 7 days. For E. taylorae, the reverse pattern of reactions was stated (3).
We studied the type strains ATCC 35317 and NCPPB 2176 to resolve this ambiguity. Both strains were obtained from two sources (see Table 1 ). Conventional tests (4) were read for 12 days (Table 1) . We could not confirm the negative results for E. cancerogenus in the ornithine decarboxylase test given by Dickey and Zumoff (1). Moreover, we found fully concordant biochemical profiles for E. cancerogenus and E. taylorae (data not shown), thus corroborating the data of Grimont and Ageron (3). Various results for gelatine hydrolysis and lactose fermentation in the literature probably reflect different periods of incubation and/or methodology, as gelatine liquefaction occurred after 12 days (three of four tests) and lactose fermentation occurred after 5 days (four of four tests).
The DNA-DNA homology findings of Grimont and Ageron (3) have been corroborated by Sakazaki (6) , and there seems to be no doubt that E. cancerogenus and E. taylorae belong to the same species. Although E. cancerogenus is a rare clinical isolate (2, 5) , the priority of the epithet cancerogenus will logically lead to reporting of E. cancerogenus in specimens from patients. Even if the epithet could be misunderstood in a clinical setting, E. cancerogenus could not be considered a nomen pen'culosum. Usage has not been consistent in recent publications (5) . Therefore, we recommend that the priority of
